{
  "id": "fad4de6787c8d191",
  "title": "ImmuneSensor Therapeutics Doses First Patient with Aicardi Gouti\u00e8res Syndrome ( AGS ) in Phase 1b Clinical Study of cGAS inhibitor , IMSB301",
  "description": "20260212T134500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/immunesensor-therapeutics-doses-first-patient-with-aicardi-goutieres-syndrome-ags-in-phase-1b-clinical-study-of-cgas-inhibitor-imsb301/2277130",
  "published_at": "20260212T134500Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/immunesensor-therapeutics-doses-first-patient-with-aicardi-goutieres-syndrome-ags-in-phase-1b-clinical-study-of-cgas-inhibitor-imsb301/2277130",
    "url_mobile": "https://www.manilatimes.net/2026/02/12/tmt-newswire/globenewswire/immunesensor-therapeutics-doses-first-patient-with-aicardi-goutieres-syndrome-ags-in-phase-1b-clinical-study-of-cgas-inhibitor-imsb301/2277130/amp",
    "title": "ImmuneSensor Therapeutics Doses First Patient with Aicardi Gouti\u00e8res Syndrome ( AGS ) in Phase 1b Clinical Study of cGAS inhibitor , IMSB301",
    "seendate": "20260212T134500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/12/935619.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}